Insights

Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.

Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings. 

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Fresh from an in-person visit to BioData World Conference 2021, Andrew Goulter discusses the role big pharma is playing in unlocking a complex new healthcare ecosystem. His hope? That effective data sharing and democratised access will deliver advantages for healthcare professionals and patients alike… 
 

Cambridge Consultants' Mike Dunkley, SVP, Bioinnovation, hosts a panel with industry leaders from Kytopen, CATALOG and Galy to explore transformative technologies for cell transfection, lab-grown cotton and DNA data storage. 

Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in bioinnovation, I’ve been part of a team addressing this issue in an ambitious project with exciting potential…

PureSentry: Can real-time contamination detection transform cell therapy manufacture? 

People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.

The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is launching a Roundtable webinar series on digital devices for 2021. Presented by subject matter experts in the pharmaceutical sciences, this is a unique opportunity to learn about the latest research and regulatory trends focused on digital devices.

Is now the time for AI and digital tech to revolutionise the whole field of pathology? Andrew Goulter, VP, Life Sciences at Cambridge Consultants certainly thinks so, as he explains here. 

Digital transformation surges on, with market sectors as diverse as automotive, consumer packaged goods and healthcare unlocking new revenue streams, greater customer insights and deeper connections with consumers.

There is no doubt that I’ve had a busy few months as head of our medtech division for the Asia Pacific region. As judge for the new MedTech Innovator APAC scheme, I’ve been on the hunt for the best and brightest medical technology start-ups in the region. This process has given me a remarkable insight into the challenges facing the region’s growing healthcare field...